apomorphine has been researched along with Psychoses, Drug in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (68.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (8.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akseki, HS; Eliküçük, B; Erbaş, O; Taşkıran, D | 1 |
| Farhan, M; Haleem, DJ | 1 |
| Harada, K; Katsuoka, M; Kondo, Y; Matsuoka, N; Mihara, T; Ni, K; Shobo, M; Yamada, H; Yamamoto, N | 1 |
| Kulisevsky, J; Martí, MJ | 1 |
| Carballo-Cordero, M; Giménez de Béjar, V | 1 |
| Chacón, JR; Mata, M | 1 |
| Bonhaus, DW; Hedley, LR; Lemaire, M; Lowe, DA; Martin, RS; Secchi, RL; Sung, E | 1 |
| Freichel, C; Künnecke, B; Maco, M; Moreau, JL; Nordquist, RE; Riemer, C; Risterucci, C; Spooren, W; von Kienlin, M | 1 |
| Bjørndal, N; Christensson, E; Gerlach, J | 1 |
| Kogan, MJ; Mulè, SJ; Verebey, K | 1 |
| Oelssner, W | 1 |
| Garey, RE; Heath, RG; McQuitty, S; Tootle, D | 1 |
| Antelman, SM; Chiodo, LA | 1 |
| Kenny, M; Leonard, BE | 1 |
| De la Vega, CE; Lal, S | 1 |
| Klawans, HL; Margolin, DI | 1 |
| Luchins, D | 1 |
| Defazio, G; Di Reda, N; Giovine, A; Lanzi, C; Lepore, V; Livrea, P; Pedone, D; Tartaglione, B | 1 |
| Turner, TH | 1 |
| Munkvad, I; Randrup, A | 1 |
| Angrist, B; Gershon, S | 1 |
| Aghajanian, GK; Asher, IM | 1 |
| Cotzias, GC | 1 |
| Ngai, SH | 1 |
| Albert, E | 1 |
6 review(s) available for apomorphine and Psychoses, Drug
| Article | Year |
|---|---|
[Candidate patient for treatment with continuous apomorphine infusion].
Topics: Aged; Antiparkinson Agents; Apomorphine; Clinical Trials as Topic; Cognition Disorders; Contraindications; Depression; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Hallucinations; Humans; Infusions, Intravenous; Middle Aged; Parkinson Disease; Patient Selection; Psychoses, Substance-Induced; Psychotic Disorders | 2012 |
[Candidate patient for subcutaneous apomorphine injection].
Topics: Abnormalities, Drug-Induced; Antiparkinson Agents; Apomorphine; Contraindications; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypotension, Orthostatic; Injections, Subcutaneous; Lactation; Levodopa; Parkinson Disease; Patient Selection; Pregnancy; Pregnancy Complications; Psychoses, Substance-Induced | 2012 |
Pharmacology and physiology of stereotyped behavior.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior; Behavior, Animal; Bipolar Disorder; Brain; Conditioning, Operant; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Grooming; Haplorhini; Humans; Psychoses, Substance-Induced; Rats; Schizophrenia; Stereotyped Behavior; Tranquilizing Agents | 1974 |
Dopamine and psychotic states: preliminary remarks.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Carbon Radioisotopes; Cats; Cocaine; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Humans; Methylphenidate; Pemoline; Phenmetrazine; Pimozide; Psychoses, Substance-Induced; Psychotic Disorders; Rats; Receptors, Cell Surface; Species Specificity; Stereotyped Behavior; Thioridazine; Tyrosine | 1974 |
Parkinsonism, levodopa, and anesthesia.
Topics: Amantadine; Anesthesia; Animals; Apomorphine; Benperidol; Blood-Brain Barrier; Brain; Cardiovascular Diseases; Catecholamines; Dihydroxyphenylalanine; Dopamine; Fentanyl; Humans; Mice; Movement Disorders; Muscle Rigidity; Parkinson Disease; Psychoses, Substance-Induced; Pulmonary Edema; Rats | 1972 |
[Therapy and problems of parkinsonism].
Topics: Adult; Aged; Amantadine; Animals; Antidepressive Agents; Apomorphine; Brain Chemistry; Brain Stem; Dihydroxyphenylalanine; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Stereotaxic Techniques; Sympathomimetics | 1971 |
1 trial(s) available for apomorphine and Psychoses, Drug
| Article | Year |
|---|---|
Apomorphine and psychopathology.
Topics: Alcoholism; Antidepressive Agents; Apomorphine; Bipolar Disorder; Clinical Trials as Topic; Depression; Humans; Libido; Male; Middle Aged; Penis; Placebos; Psychiatric Status Rating Scales; Psychomotor Disorders; Psychoses, Substance-Induced; Schizophrenia | 1975 |
18 other study(ies) available for apomorphine and Psychoses, Drug
| Article | Year |
|---|---|
Antipsychotic-like effect of trimetazidine in a rodent model.
Topics: Animals; Antipsychotic Agents; Apomorphine; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Male; Psychoses, Substance-Induced; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Treatment Outcome; Trimetazidine | 2013 |
Inhibition of apomorphine-induced behavioral sensitization in rats pretreated with fluoxetine.
Topics: Animals; Apomorphine; Behavior, Animal; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Fluoxetine; Male; Motor Activity; Psychoses, Substance-Induced; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2015 |
Norzotepine, a major metabolite of zotepine, exerts atypical antipsychotic-like and antidepressant-like actions through its potent inhibition of norepinephrine reuptake.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antipsychotic Agents; Apomorphine; Body Temperature; Catalepsy; Cell Line; Central Nervous System Stimulants; CHO Cells; Cricetinae; Cricetulus; Dibenzothiepins; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Norepinephrine; Psychoses, Substance-Induced; Reserpine; Swimming | 2010 |
[Treatment of apomorphine infusion adverse effects: subcutaneous nodules and neuropsychiatric complications].
Topics: Adrenal Cortex Hormones; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Cholinesterase Inhibitors; Combined Modality Therapy; Disease Susceptibility; Dopamine Agonists; Drug Eruptions; Hallucinations; Humans; Infusions, Subcutaneous; Mental Disorders; Parkinson Disease; Physical Therapy Modalities; Psychomotor Agitation; Psychoses, Substance-Induced; Severity of Illness Index; Sleep Wake Disorders | 2012 |
Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.
Topics: Animals; Antipsychotic Agents; Apomorphine; Arousal; Attention; Behavior, Animal; Cyclohexanols; Dextroamphetamine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Hallucinogens; Male; Motor Activity; Piperidines; Psychoses, Substance-Induced; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Reflex, Startle; Rimonabant; Stereotyped Behavior | 2003 |
Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats.
Topics: Animals; Antipsychotic Agents; Apomorphine; Aripiprazole; Brain; Catalepsy; Data Interpretation, Statistical; Dopamine Agonists; Hallucinogens; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Motor Activity; N-Methylaspartate; Piperazines; Postural Balance; Psychoses, Substance-Induced; Quinolones; Rats; Rats, Sprague-Dawley; Reflex, Startle; Serotonin Receptor Agonists | 2008 |
Methylphenidate, apomorphine, THIP, and diazepam in monkeys: dopamine-GABA behavior related to psychoses and tardive dyskinesia.
Topics: Animals; Apomorphine; Chlorocebus aethiops; Diazepam; Dopamine; Drug Interactions; Dyskinesia, Drug-Induced; Female; gamma-Aminobutyric Acid; Hallucinations; Humans; Isoxazoles; Male; Methylphenidate; Motor Activity; Oxazoles; Psychoses, Substance-Induced | 1984 |
Phencyclidine-induced stereotype in rats: effects of methadone, apomorphine, and naloxone.
Topics: Animals; Apomorphine; Brain Chemistry; Disease Models, Animal; Humans; Male; Methadone; Motor Activity; Naloxone; Phencyclidine; Psychoses, Substance-Induced; Rats; Rats, Inbred Strains; Stereotyped Behavior; Time Factors | 1981 |
[Hallucinogen caused motility disorders in rats as potential psychosis relevant animal model].
Topics: Animals; Apomorphine; Brain; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Hallucinogens; Humans; Lysergic Acid Diethylamide; Methysergide; Motor Activity; Psychoses, Substance-Induced; Rats; Receptors, Dopamine; Receptors, Serotonin; Serotonin | 1982 |
The effects of apomorphine and haldol on PCP induced behavioral and motor abnormalities in the rat.
Topics: Animals; Apomorphine; Behavior, Animal; Haloperidol; Humans; Male; Motor Activity; Phencyclidine; Psychoses, Substance-Induced; Rats; Receptors, Dopamine | 1980 |
Dopamine autoreceptor subsensitivity: a mechanism common to the treatment of depression and the induction of amphetamine psychosis.
Topics: Amitriptyline; Amphetamine; Animals; Antidepressive Agents, Tricyclic; Apomorphine; Depressive Disorder; Electroshock; Humans; Imipramine; In Vitro Techniques; Iprindole; Neurons; Psychoses, Substance-Induced; Receptors, Dopamine; Substantia Nigra; Time Factors | 1981 |
Some neuropharmacological aspects of schizophrenia: a short review.
Topics: Amphetamines; Animals; Apomorphine; Disease Models, Animal; Hallucinogens; Humans; Psychoses, Substance-Induced; Rats; Schizophrenia, Paranoid | 1978 |
Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.
Topics: Amphetamine; Animals; Apomorphine; Behavior; Behavior, Animal; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Levodopa; Movement Disorders; Psychoses, Substance-Induced; Reaction Time; Receptors, Drug; Schizophrenia; Stereotyped Behavior; Substance-Related Disorders | 1975 |
The dopamine hypothesis of schizophrenia. A critical analysis.
Topics: Acetylcholine; Amphetamine; Apomorphine; Cocaine; Dopamine; Electroconvulsive Therapy; gamma-Aminobutyric Acid; Humans; Levodopa; Methyldopa; Methyltyrosines; Models, Neurological; Psychoses, Substance-Induced; Schizophrenia; Tranquilizing Agents | 1975 |
Dopaminomimetic action of diphenylhydantoin in rat striatum: effect on homovanillic acid and cyclic AMP levels.
Topics: Animals; Apomorphine; Corpus Striatum; Cyclic AMP; Dyskinesia, Drug-Induced; Haloperidol; Homovanillic Acid; Humans; Male; Phenylacetates; Phenytoin; Psychoses, Substance-Induced; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1985 |
The dopamine hypothesis.
Topics: Apomorphine; Bromocriptine; Humans; Psychoses, Substance-Induced | 1988 |
6-Hydroxydopamine lesions of olfactory tubercles and caudate nuclei: effect on amphetamine-induced stereotyped behavior in rats.
Topics: Amphetamine; Animals; Apomorphine; Behavior; Behavior, Animal; Brain Chemistry; Brain Mapping; Caudate Nucleus; Disease Models, Animal; Dopamine; Histocytochemistry; Humans; Hydroxydopamines; Limbic System; Male; Microscopy, Fluorescence; Nerve Degeneration; Neural Pathways; Olfactory Bulb; Psychoses, Substance-Induced; Rats; Stereotyped Behavior; Synaptic Transmission | 1974 |
Levodopa, manganese, and degenerations of the brain.
Topics: Administration, Oral; Animals; Apomorphine; Blood Urea Nitrogen; Brain Diseases; Carbon Radioisotopes; Chemical Phenomena; Chemistry; Chronic Disease; Dietary Proteins; Dopamine; Drug Therapy, Combination; Growth Hormone; Humans; Injections; Levodopa; Manganese Poisoning; Movement Disorders; Neutron Activation Analysis; Parkinson Disease; Psychoses, Substance-Induced; Radioisotopes | 1974 |